A nitric oxide synthase inhibitor (l-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria

Brain Research

Volumn 1099, Issue 1, 2006, Pages 82-87

  Rawls, Scott M ^a   Rodriguez, Tonatiu ^a   Baron, David A ^a   Raffa, Robert B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

Cannabinoids; Cocaine; NO; Planaria; WIN 55212 2; Withdrawal

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR AGONIST; COCAINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR;

ABSTINENCE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; DRUG WITHDRAWAL; ENANTIOMER; LOCOMOTION; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; TURBELLARIA; WITHDRAWAL SYNDROME;

ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; ANIMALS; BEHAVIOR, ANIMAL; CANNABINOIDS; COCAINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; MORPHOLINES; MOTOR ACTIVITY; NAPHTHALENES; NG-NITROARGININE METHYL ESTER; PLANARIANS; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

DUGESIA DOROTOCEPHALA; PLANARIA; TURBELLARIA;

EID: 33746084884     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.04.103     Document Type: Article

References (47)

1. Adams M.L., Kalicki J.M., Meyer E.R., and Cicero T.J. Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor. NG-nitro-l-arginine methyl ester. Life Sci. 52 (1993) PL245-PL249
2. Algeri S., Carolei A., Ferretti P., Gallone C., Palladini G., and Venturini G. Effects of dopaminergic agents on monoamine levels and motor behaviour in Planaria. Comp. Biochem. Physiol. 74C (1983) 27-29
3. Benwell M.E., and Balfour D.J. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br. J. Pharmacol. 105 (1992) 849-856
4. Bhargava H.N., and Kumar S. Effect of multiple injections of U-50, 488H, a kappa-opioid receptor agonist, on the activity of nitric oxide synthase in brain regions and spinal cord of mice. Gen. Pharmacol. 29 (1997) 397-399
5. Bhargava H.N., and Kumar S. Sensitization to the locomotor stimulant activity of cocaine is associated with increases in nitric oxide synthase activity in brain regions and spinal cord of mice. Pharmacology 55 (1997) 292-298
6. Bhargava H.N., and Thorat S.N. Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome. Pharmacology 52 (1996) 86-91
7. Breder C.D., and Saper C.B. Expression of inducible cyclooxygenase mRNA in the mouse brain after systemic administration of bacterial lipopolysaccharide. Brain Res. 713 (1996) 64-69
8. Byrnes J.J., Pantke M.M., Onton J.A., and Hammer Jr. R.P. Inhibition of nitric oxide synthase in the ventral tegmental area attenuates cocaine sensitization in rats. Prog. Neuro-psychopharmacol. Biol. Psychiatry 24 (2000) 261-273
9. Capasso A., Sorrentino L., and Pinto A. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists. Eur. J. Pharmacol. 359 (1998) 127-131
10. Cappendijk S.L., de Vries R., and Dzoljic M.R. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci. Lett. 162 (1993) 97-100
11. Carboni E., Imperato A., Perezzani L., and Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28 (1989) 653-661
12. Carelli R.M., and Wightman R.M. Functional microcircuitry in the accumbens underlying drug addiction: insights from real-time signaling during behavior. Curr. Opin. Neurobiol. 14 (2004) 763-768
13. Carolei A., Margotta V., and Palladini G. Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations. Neuropsychobiology 1 (1975) 355-364
14. Chen J.P., Paredes W., Li J., Smith D., Lowinson J., and Gardner E.L. Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacol. (Berl.) 102 (1990) 156-162
15. Compton D.R., Gold L.H., Ward S.J., Balster R.L., and Martin B.R. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 263 (1992) 1118-1126
16. Cuellar B., Fernandez A.P., Lizasoain I., Moro M.A., Lorenzo P., Bentura M.L., Rodrigo J., and Leza J.C. Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmacol. (Berl.) 148 (2000) 66-73
17. D'Ambra T.E., Estep K.G., Bell M.R., Eissenstat M.A., Josef K.A., Ward S.J., Haycock D.A., Baizman E.R., Casiano F.M., Beglin N.C., Chippari S.M., Grego J.D., Kullnig R.K., and Daley G.T. Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. J. Med. Chem. 35 (1992) 124-135
18. Di Chiara G., Bassareo V., Fenu S., De Luca M.A., Spina L., Cadoni C., Acquas E., Carboni E., Valentini V., and Lecca D. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 Suppl. 1 (2004) 227-241
19. Gessa G.L., Melis M., Muntoni A.L., and Diana M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur. J. Pharmacol. 341 (1998) 39-44
20. Haracz J.L., MacDonall J.S., and Sircar R. Effects of nitric oxide synthase inhibitors on cocaine sensitization. Brain Res. 746 (1997) 183-189
21. Itzhak Y., and Martin J.L. Blockade of alcohol-induced locomotor sensitization and conditioned place preference in DBA mice by 7-nitroindazole. Brain Res. 858 (2000) 402-407
22. Kalivas P.W., and Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 162 (2005) 1403-1413
23. Kilbinger H. Modulation of acetylcholine release by nitric oxide. Prog. Brain Res. 109 (1996) 219-224
24. Kimes A.S., Vaupel D.B., and London E.D. Modulation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacol. (Berl.) 112 (1993) 521-524
25. Liang D.Y., and Clark J.D. Modulation of the NO/CO-cGMP signaling cascade during chronic morphine exposure in mice. Neurosci. Lett. 365 (2004) 73-77
26. London E.D., Kimes A.S., and Vaupel D.B. Inhibitors of nitric oxide synthase and the opioid withdrawal syndrome. NIDA Res. Monogr. 147 (1995) 170-181
27. Martin B.R., Compton D.R., Thomas B.F., Prescott W.R., Little P.J., Razdan R.K., Johnson M.R., Melvin L.S., Mechoulam R., and Ward S.J. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol. Biochem. Behav. 40 (1991) 471-478
28. McGregor I.S. Marijuana addiction. Science 277 (1997) 749-750 (author reply 750-752)
29. Moghaddam B., and Bunney B.S. Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: comparison to amphetamine. Synapse 4 (1989) 156-161
30. Nisell M., Nomikos G.G., and Svensson T.H. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16 (1994) 36-44
31. Pagliaro L.A., and Pagliaro A.M. Pagliaros' comprehensive guide to drugs and substances of abuse (2004), American Pharmacists Association, Washington DC 205-213
32. Palladini G., Ruggieri S., Stocchi F., De Pandis M.F., Venturini G., and Margotta V. A pharmacological study of cocaine activity in Planaria. Comp. Biochem. Physiol. C115 (1996) 41-45
33. Panikkar G.P. Cocaine Addiction: Neurobiology and Related Current Research in Pharmacotherapy. Subst. Abuse 20 (1999) 149-166
34. Rada P., Mark G.P., Pothos E., and Hoebel B.G. Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats. Neuropharmacology 30 (1991) 1133-1136
35. Raffa R.B., and Valdez J.M. Cocaine withdrawal in Planaria. Eur. J. Pharmacol. 430 (2001) 143-145
36. Raffa R.B., and Desai P. Description and quantification of cocaine withdrawal signs in Planaria. Brain Res. 1032 (2005) 200-202
37. Raffa R.B., Valdez J.M., Holland L.J., and Schulingkamp R.J. Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint. J. Pharmacol. Toxicol. Methods 45 (2001) 223-226
38. Raffa R.B., Stagliano G.W., and Umeda S. κ-opioid withdrawal in Planaria. Neurosci. Lett. 349 (2003) 139-142
39. Rawls S.M., Cabassa J., Geller E.B., and Adler M.W. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia. J. Pharmacol. Exp. Ther. 301 (2002) 963-968
40. Rees D.D., Palmer R.M., Schulz R., Hodson H.F., and Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101 (1990) 746-752
41. Tanda G., Pontieri F.E., and DiChiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276 (1997) 2048-2050
42. Umeda S., Stagliano G.W., and Raffa R.B. Cocaine and κ-opioid withdrawal in Planaria blocked by d-, but not l-, glucose. Brain Res. 1018 (2004) 181-185
43. Vaupel D.B., Kimes A.S., and London E.D. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology 13 (1995) 315-322
44. Venturini G., Stocchi F., Margotta V., Ruggieri S., Bravi D., Bellantuono P., and Palladini G. A pharmacological study of dopaminergic receptor in Planaria. Neuropharmacology 28 (1989) 1377-1382
45. Wise R.A. The role of reward pathways in the development of drug dependence. Pharmacol. Ther. 35 (1987) 227-263
46. Wong C.S., Hsu M.M., Chou Y.Y., Tao P.L., and Tung C.S. Morphine tolerance increases [3H]MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord. Br. J. Anaesth. 85 (2000) 587-591
47. Zweier J.L., Samouilov A., and Kuppusamy P. Non-enzymatic nitric oxide synthesis in biological systems. Biochim. Biophys. Acta 1411 (1999) 250-262